Targeting O6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy.
AffiliationInstitute of Toxicology, University Medical Center, Obere Zahlbacher Str. 67, 55131, Mainz, Germany. email@example.com
MetadataShow full item record
AbstractO (6)-methylguanine-DNA methyltransferase (MGMT) repairs the cancer chemotherapy-relevant DNA adducts, O (6)-methylguanine and O (6)-chloroethylguanine, induced by methylating and chloroethylating anticancer drugs, respectively. These adducts are cytotoxic, and given the overwhelming evidence that MGMT is a key factor in resistance, strategies for inactivating MGMT have been pursued. A number of drugs have been shown to inactivate MGMT in cells, human tumour models and cancer patients, and O (6)-benzylguanine and O (6)-[4-bromothenyl]guanine have been used in clinical trials. While these agents show no side effects per se, they also inactivate MGMT in normal tissues and hence exacerbate the toxic side effects of the alkylating drugs, requiring dose reduction. This might explain why, in any of the reported trials, the outcome has not been improved by their inclusion. It is, however, anticipated that, with the availability of tumour targeting strategies and hematopoetic stem cell protection, MGMT inactivators hold promise for enhancing the effectiveness of alkylating agent chemotherapy.
CitationTargeting O6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy. 2010, 67 (21):3663-81 Cell Mol Life Sci
JournalCellular and Molecular Life Sciences
- The specific role of O<sup>6</sup>-methylguanine-DNA methyltransferase inhibitors in cancer chemotherapy.
- Authors: Sun G, Zhao L, Zhong R, Peng Y
- Issue date: 2018 Aug 1
- S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.
- Authors: Juillerat A, Juillerat-Jeanneret L
- Issue date: 2007 Mar
- Targeted modulation of MGMT: clinical implications.
- Authors: Liu L, Gerson SL
- Issue date: 2006 Jan 15
- O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry.
- Authors: Christmann M, Verbeek B, Roos WP, Kaina B
- Issue date: 2011 Dec
- Multidrug Efflux Pumps Attenuate the Effect of MGMT Inhibitors.
- Authors: Tomaszowski KH, Schirrmacher R, Kaina B
- Issue date: 2015 Nov 2